Omega Healthcare Investors, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $590.2M | $406.3M | $242.2M | $438.8M | $428.3M | $163.5M | $351.9M | $293.9M |
| Depreciation & Amortization | $325.2M | $304.6M | $319.7M | $332.4M | $342.0M | $329.9M | $301.7M | $281.3M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $44.2M | $36.7M | $35.1M | $27.3M | $21.4M | $18.8M | $15.4M | $16.0M |
| Net Cash from Operating Activities | $878.6M | $749.4M | $617.7M | $625.7M | $722.1M | $708.3M | $553.7M | $499.4M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | $604.0M | $5.1M | $59.6M | $105.7M |
| Net Cash from Investing Activities | $-539.8M | $-671.2M | $-770.0K | $442.9M | $-524.2M | $-89.1M | $-379.0M | $-173.2M |
| Financing Activities | ||||||||
| Dividends Paid | $780.4M | $685.4M | $643.9M | $632.9M | $637.6M | $612.3M | $564.1M | $528.7M |
| Stock Repurchases | — | — | — | $142.3M | — | — | — | — |
| Net Cash from Financing Activities | $-838.3M | $26.3M | $-473.3M | $-789.4M | $-341.1M | $-485.5M | $-154.0M | $-410.7M |
| Net Change in Cash | $-494.2M | $104.0M | $144.1M | $276.2M | $-143.1M | $134.2M | $21.7M | $-85.1M |
| Free Cash Flow | — | — | — | — | — | — | — | — |